Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited ... There is currently no vaccine to prevent or medicine to treat chikungunya virus infection.On 30 September 2016, Cadila ...
India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...
Zydus Lifesciences Limited received final approval from the US Food and Drug Administration (USFDA) to manufacture Ketoconazole Shampoo, 2 per cent, according to the announcement issued by the ...
The stock of Zydus Lifesciences has been in a steady decline since August last year after facing resistance at ₹1,300. After witnessing some consolidation between ₹940 and ₹1,000 in December ...
Zydus Lifesciences announced it is negotiating to acquire a majority stake in French medtech firm Amplitude Surgical for ...
India's Zydus Lifesciences is set to acquire an 85.6% stake in France's Amplitude Surgical for nearly $280 million to expand ...
Other PBC candidates coming through the collective industry pipeline include CymaBay's seladelpar and Zydus Cadila's saroglitazar - both PPAR agonists – as well as Genkyotex' NOX 1 and 4 ...
Duke clinicians and patients discuss how approaches such as talk, music, and art therapy can address psychosocial issues that cancer survivors often face. Beyond Cancer: Building Bridges Experts ...
Medical research involves research in a wide range of fields, such as biology, chemistry, pharmacology and toxicology with the goal of developing new medicines or medical procedures or improving ...
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Nippon India Small Cap Fund - Direct (IDCW) 467.76 29,95,942 0.92 Nippon India Small Cap Fund - Direct (G) 467.76 29,95,942 0.92 Nippon India Small Cap Fund - Direct ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results